Ocugen Inc. [NASDAQ: OCGN] plunged by -$0.06 during the normal trading session on Monday and reaching a high of $1.04 during the day while it closed the day at $0.98. The company report on March 6, 2023 that Ocugen Appoints Quan A. Vu to Chief Financial Officer & Chief Business Officer.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
“Quan has quickly become a tremendous asset for Ocugen and his comprehensive healthcare and financial expertise is providing valuable insight toward reaching our corporate goals,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “With Quan now overseeing both finance and business development, there will be a fully integrated approach to financial strategy—pursuing new partnerships and engaging with the investment community.”.
Ocugen Inc. stock has also gained 0.71% of its value over the past 7 days. However, OCGN stock has declined by -35.34% in the 3 months of the year. Over the past six months meanwhile, it has lost -62.48% and lost -24.39% year-on date.
The market cap for OCGN stock reached $213.88 million, with 216.59 million shares outstanding and 215.47 million shares in the current float. Compared to the average trading volume of 5.68M shares, OCGN reached a trading volume of 5756294 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Ocugen Inc. [OCGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for OCGN shares is $4.83 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on OCGN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for Ocugen Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on March 01, 2023. While these analysts kept the previous recommendation, Mizuho raised their target price to Buy. The new note on the price target was released on August 23, 2022, representing the official price target for Ocugen Inc. stock. Previously, the target price had yet another raise to $8, while ROTH Capital analysts kept a Buy rating on OCGN stock.
The Average True Range (ATR) for Ocugen Inc. is set at 0.07 The Price to Book ratio for the last quarter was 2.23, with the Price to Cash per share for the same quarter was set at 0.47.
OCGN stock trade performance evaluation
Ocugen Inc. [OCGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.71. With this latest performance, OCGN shares dropped by -26.10% in over the last four-week period, additionally sinking by -62.48% over the last 6 months – not to mention a drop of -70.12% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for OCGN stock in for the last two-week period is set at 39.01, with the RSI for the last a single of trading hit 39.10, and the three-weeks RSI is set at 39.69 for Ocugen Inc. [OCGN]. The present Moving Average for the last 50 days of trading for this stock 1.1761, while it was recorded at 1.0034 for the last single week of trading, and 1.8761 for the last 200 days.
Ocugen Inc. [OCGN]: An insightful look at the core fundamentals
Ocugen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 7.20 and a Current Ratio set at 7.20.
Ocugen Inc. [OCGN]: Insider Ownership positions
There are presently around $89 million, or 37.90% of OCGN stock, in the hands of institutional investors. The top three institutional holders of OCGN stocks are: STATE STREET CORP with ownership of 30,121,024, which is approximately 15.818% of the company’s market cap and around 0.40% of the total institutional ownership; BLACKROCK INC., holding 15,061,361 shares of the stock with an approximate value of $14.8 million in OCGN stocks shares; and VANGUARD GROUP INC, currently with $11.66 million in OCGN stock with ownership of nearly 1.347% of the company’s market capitalization.
58 institutional holders increased their position in Ocugen Inc. [NASDAQ:OCGN] by around 12,748,446 shares. Additionally, 57 investors decreased positions by around 5,087,862 shares, while 28 investors held positions by with 72,202,454 shares. The mentioned changes placed institutional holdings at 90,038,762 shares, according to the latest SEC report filing. OCGN stock had 18 new institutional investments in for a total of 1,592,505 shares, while 30 institutional investors sold positions of 2,019,525 shares during the same period.